Skip to content
Press

Advancing biomarker research in endometriosis at SEUD 2026

Published on Apr 18, 2026
Presentation at SEUD 2026

At SEUD 2026, endogene.bio shared new research on molecular profiling from menstrual blood and its potential to improve our understanding of patient heterogeneity and treatment response in endometriosis.

About endogene.bio

endogene.bio generates high-resolution biological data from menstrual blood, unlocking a previously inaccessible layer of human uterine biology. Our platform enables disease understanding, patient stratification, and therapeutic discovery across uterine health.